In this podcast, Associate Professor Joanne Rimmer provides an in-depth analysis of the surgical management of chronic rhinosinusitis (CRS) with nasal polyps. She highlights the importance of structural nasal anatomy in patient assessments and discusses various types of rhinitis and sinusitis with an emphasis on evolving classifications. Professor Rimmer details common symptoms, surgical procedures such as septoplasty and inferior turbinoplasty, and the necessity for patient education regarding surgical outcomes. She introduces functional endoscopic sinus surgery (FESS) and shares case studies demonstrating the need for tailored approaches based on CRS subtypes. The episode also covers the role of biologics in CRS management while affirming the ongoing relevance of surgery for severe cases. Professor Rimmer concludes by addressing recurrence patterns of nasal polyps and the importance of an integrative approach for effective long-term treatment strategies.

This podcast was recorded live at the Monash Lung and Sleep Institute: COPD, Interstitial lung diseases, upper airway pathologies and occupational lung diseases State of the Art Symposium in Melbourne.

-------------------------------------------------------------------------------

Access thousands of additional conference podcasts and 'full video' podcasts including synchronised PowerPoint slides at https://www.armchairmedical.tv/podcasts

Disclaimer: Content is for health professionals and general educational purposes only. It is not medical advice or a substitute for independent clinical judgement. Always consult current guidelines, product information and local protocols. Views expressed are those of the presenters and not necessarily ArmchairMedical. ArmchairMedical accepts no responsibility or liability for any loss or harm resulting from reliance on the information provided.

Visit https://www.armchairmedical.tv/podcasts for more information.

In today's podcast, Victoria Silvestro and Dr Shannon Lin discuss sustainable diets and lifestyle modifications for patients using GLP-1 medications to achieve weight loss and improve diabetes outcomes. They highlight the critical link between obesity and diabetes and recommend an initial 10% weight loss target for health benefits.

The conversation covers the importance of lifestyle changes, including dietary strategies like Very Low-Calorie Diets and diabetes-specific nutrition formulas. A comparative analysis of various Very Low-Calorie Diets products and their effects on glycemic management is presented, emphasizing the role of monitoring and insulin adjustments.

The session further explores the tailored benefits of diabetes-specific nutrition formulas for individuals facing dietary challenges, reinforcing the significance of integrating both strategies into personalized diabetes care plans to promote lasting lifestyle changes.

This podcast was recorded live at the Western Sydney Diabetes Masterclass in Sydney.

-------------------------------------------------------------------------------

Access thousands of premium conference podcasts and 'full video' podcasts including synchronised PowerPoint slides at https://www.armchairmedical.tv/podcasts

General Practitioners: Earn your full year's worth of CPD including Educational Activities, Reviewing Performance and Measuring Outcomes CPD Hours.

Discover more at https://www.armchairmedical.tv/podcasts

Press play. You’re at the conference.

In this episode of ArmchairMedical Conference Podcasts, we bring Australia’s leading medical conference education straight to your headphones.

No travel.

No full days away from clinic.

No disruption to your life.

Each episode features real conference lectures, captured live and carefully curated into short, practical, evidence-based podcasts designed for busy general practitioners.

Whether you’re commuting, exercising, or moving through the gaps of your day, this is conference-quality learning that fits real GP life.

If you value staying at the leading edge of medicine, but don’t have the time to attend every conference, this is the smart way to do it.

🎧 Press play. You’re at the conference.

ArmchairMedical Conference Podcasts transform Australia’s best medical conferences into on-demand audio education for GPs. Learn from leading clinicians and experts, anytime and anywhere, in a format designed to work with - not against - your day.

⭐ Rate this episode

➕ Follow the podcast

💬 Share it with a colleague who’d value conference learning without the time away

Disclaimer: Content is for health professionals and general educational purposes only. It is not medical advice or a substitute for independent clinical judgement. Always consult current guidelines, product information and local protocols. Views expressed are those of the presenters and not necessarily ArmchairMedical. ArmchairMedical accepts no responsibility or liability for any loss or harm resulting from reliance on the information provided.

Visit https://www.armchairmedical.tv/podcasts for more information.

This podcast by Associate Professor Yet Khor offers an update on interstitial pneumonia (IP) and interstitial lung disease (ILD), focusing on advancements in classification and diagnosis over the past two decades. Dr. Khor discusses the significance of recognizing both idiopathic and secondary causes, highlights key developments, such as the identification of idiopathic nonspecific interstitial pneumonia (NSIP), and advocates for improved diagnostic protocols, particularly concerning antigen-negative fibrotic hypersensitivity pneumonitis.

In a significant part of her discussion, Dr. Khor introduces the concept of disease behavior classification, which provides insights into patient prognosis and treatment goals. The lecture emphasizes the recognition of mixed presentations in patients, where they may exhibit features of multiple patterns rather than fitting neatly into a single classification. This highlights the complication of diagnosing ILD.

The podcast transitions into an exploration of recent findings related to the complications of diagnosing antigen-negative fibrotic hypersensitivity pneumonitis (HP), where a subset of patients exhibit progressive lung function decline despite the absence of identifiable antigens. Dr. Khor raises important considerations regarding the implications of these cases and the clinical challenges they pose, thus advocating for a re-evaluation of current diagnostic protocols and potential reclassification to spur further investigation in this area.

This podcast was recorded live at the Monash Lung and Sleep Institute: COPD, Interstitial lung diseases, upper airway pathologies and occupational lung diseases State of the Art Symposium in Melbourne.

-------------------------------------------------------------------------------

Access thousands of additional conference podcasts and 'full video' podcasts including synchronised PowerPoint slides at https://www.armchairmedical.tv/podcasts

Disclaimer: Content is for health professionals and general educational purposes only. It is not medical advice or a substitute for independent clinical judgement. Always consult current guidelines, product information and local protocols. Views expressed are those of the presenters and not necessarily ArmchairMedical. ArmchairMedical accepts no responsibility or liability for any loss or harm resulting from reliance on the information provided.

Visit https://www.armchairmedical.tv/podcasts for more information.